Anti-PTPRQ monoclonal antibody

Pre-made anti-PTPRQ monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PTPRQ/PTPRQ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1460-Ab-1/ GM-Tg-hg-IP1460-Ab-2Anti-Human PTPRQ monoclonal antibodyHuman
GM-Tg-rg-IP1460-Ab-1/ GM-Tg-rg-IP1460-Ab-2Anti-Rat PTPRQ monoclonal antibodyRat
GM-Tg-mg-IP1460-Ab-1/ GM-Tg-mg-IP1460-Ab-2Anti-Mouse PTPRQ monoclonal antibodyMouse
GM-Tg-cynog-IP1460-Ab-1/ GM-Tg-cynog-IP1460-Ab-2Anti-Cynomolgus/ Rhesus macaque PTPRQ monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1460-Ab-1/ GM-Tg-felg-IP1460-Ab-2Anti-Feline PTPRQ monoclonal antibodyFeline
GM-Tg-cang-IP1460-Ab-1/ GM-Tg-cang-IP1460-Ab-2Anti-Canine PTPRQ monoclonal antibodyCanine
GM-Tg-bovg-IP1460-Ab-1/ GM-Tg-bovg-IP1460-Ab-2Anti-Bovine PTPRQ monoclonal antibodyBovine
GM-Tg-equg-IP1460-Ab-1/ GM-Tg-equg-IP1460-Ab-2Anti-Equine PTPRQ monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1460-Ab-1/ GM-Tg-hg-IP1460-Ab-2; GM-Tg-rg-IP1460-Ab-1/ GM-Tg-rg-IP1460-Ab-2;
GM-Tg-mg-IP1460-Ab-1/ GM-Tg-mg-IP1460-Ab-2; GM-Tg-cynog-IP1460-Ab-1/ GM-Tg-cynog-IP1460-Ab-2;
GM-Tg-felg-IP1460-Ab-1/ GM-Tg-felg-IP1460-Ab-2; GM-Tg-cang-IP1460-Ab-1/ GM-Tg-cang-IP1460-Ab-2;
GM-Tg-bovg-IP1460-Ab-1/ GM-Tg-bovg-IP1460-Ab-2; GM-Tg-equg-IP1460-Ab-1/ GM-Tg-equg-IP1460-Ab-2
Products NameAnti-PTPRQ monoclonal antibody
Formatmab
Target NamePTPRQ
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PTPRQ monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1460-Ag-1Recombinant multi-species PTPRQ/ DFNA73/ DFNB84 protein


    Target information

    Target IDGM-IP1460
    Target NamePTPRQ
    Gene ID374462,237523,360417,697153,482581,101091541,522188,100060666
    Gene Symbol and SynonymsDFNA73,DFNB84,DFNB84A,PTPGMC1,PTPRQ,R-PTP-Q,rPTP-GMC1
    Uniprot AccessionQ9UMZ3,O88488
    Uniprot Entry NamePTPRQ_HUMAN,PTPRQ_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000139304
    Target ClassificationN/A

    The target: PTPRQ, gene name: PTPRQ, also named as DFNA73, DFNB84, DFNB84A, PTPGMC1, R-PTP-Q. This locus encodes a member of the type III receptor-like protein-tyrosine phosphatase family. The encoded protein catalyzes the dephosphorylation of phosphotyrosine and phosphatidylinositol and plays roles in cellular proliferation and differentiation. Mutations at this locus have been linked to autosomal recessive deafness. [provided by RefSeq, Mar 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.